Overview
Maya Styner is an Endocrinologist in Chapel Hill, North Carolina. Dr. Styner is rated as an Experienced provider by MediFind in the treatment of Neuroblastoma. Her top areas of expertise are Osteoporosis, Postmenopausal Osteoporosis, Juvenile Primary Osteoporosis, and Hyperparathyroidism.
Her clinical research consists of co-authoring 38 peer reviewed articles. MediFind looks at clinical research from the past 15 years.
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE-MEDICAID PLAN
- OTHER COMMERCIAL
- OTHER MEDICARE
- OTHER MEDICARE PART D
- PPO
- EPO
- HMO
- PPO
- HMO
- INDEMNITY
- POS
- PPO
- EPO
- POS
- PPO
- OTHER MANAGED MEDICAID
- OTHER MEDICAID
- STATE MEDICAID
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE
- OTHER MEDICARE PART D
Locations
101 Manning Dr, Chapel Hill, NC 27514
100 Eastowne Dr, Chapel Hill, NC 27514
Additional Areas of Focus
Dr. Styner has provided the following conditions as areas of focus. Please note that we may not have enough data to validate their experience in some of these conditions.
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Duke Endocrinology Clinic - Clinic 1A
I love endocrinology because of the way it explores and explains the complex interactions between different organ systems in our body. I value the opportunity I get to connect with patients and develop long-lasting, trusting relationships with them. My highest priority is to listen to my patients and understand their questions and concerns, provide them with necessary information and tools, and then work together as a team to develop a comprehensive, evidence-based treatment plan which is the most beneficial to them. I am also a member of the Endocrine Society. Outside of work, I enjoy listening to music and spending time with my husband and two daughters. Dr. Sharma is rated as an Advanced provider by MediFind in the treatment of Neuroblastoma. Her top areas of expertise are Addison's Disease, Secondary Adrenal Insufficiency, Triple A Syndrome, and Pheochromocytoma.
Julie Sharpless is an Endocrinologist in Chapel Hill, North Carolina. Dr. Sharpless is rated as an Advanced provider by MediFind in the treatment of Neuroblastoma. Her top areas of expertise are Pituitary Tumor, Prolactinoma, Acromegaly, and Triple A Syndrome.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Distinguished
- OsteoporosisDr. Styner isDistinguished. Learn about Osteoporosis.
- Postmenopausal OsteoporosisDr. Styner isDistinguished. Learn about Postmenopausal Osteoporosis.
- Advanced
- HyperparathyroidismDr. Styner isAdvanced. Learn about Hyperparathyroidism.
- Juvenile Primary OsteoporosisDr. Styner isAdvanced. Learn about Juvenile Primary Osteoporosis.
- Experienced
- Addison's DiseaseDr. Styner isExperienced. Learn about Addison's Disease.
- Adrenal CancerDr. Styner isExperienced. Learn about Adrenal Cancer.
- Adrenocortical CarcinomaDr. Styner isExperienced. Learn about Adrenocortical Carcinoma.
- Anaplastic Thyroid CancerDr. Styner isExperienced. Learn about Anaplastic Thyroid Cancer.
- Familial Glucocorticoid DeficiencyDr. Styner isExperienced. Learn about Familial Glucocorticoid Deficiency.
- Familial Hypocalciuric Hypercalcemia Type 1